Assessment of P2Y12 inhibitor usage and switching in acute coronary syndrome patients undergoing percutaneous coronary revascularization.
about
Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registryContemporary use of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry.
P2860
Assessment of P2Y12 inhibitor usage and switching in acute coronary syndrome patients undergoing percutaneous coronary revascularization.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Assessment of P2Y12 inhibitor ...... us coronary revascularization.
@en
Assessment of P2Y12 inhibitor ...... us coronary revascularization.
@nl
type
label
Assessment of P2Y12 inhibitor ...... us coronary revascularization.
@en
Assessment of P2Y12 inhibitor ...... us coronary revascularization.
@nl
prefLabel
Assessment of P2Y12 inhibitor ...... us coronary revascularization.
@en
Assessment of P2Y12 inhibitor ...... us coronary revascularization.
@nl
P2093
P1476
Assessment of P2Y12 inhibitor ...... us coronary revascularization.
@en
P2093
A J Conrad Smith
Catalin Toma
John T Schindler
Joon S Lee
Michael S Sharbaugh
Mrudula Kudaravalli
Oscar C Marroquin
Sameer J Khandhar
Suresh R Mulukutla
P304
P356
10.1016/J.IJCARD.2016.08.144
P407
P577
2016-08-08T00:00:00Z